Karschnia P, Rejeski K, Subklewe M, von Baumgarten L, et al. Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Neurology 2023;100:687-688.
PMID: 37012062